Vivo Capital’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-655,057
| Closed | -$5.33M | – | 45 |
|
|
2023
Q4 | $5.33M | Hold |
655,057
| – | – | 0.44% | 35 |
|
|
2023
Q3 | $2.98M | Hold |
655,057
| – | – | 0.33% | 42 |
|
|
2023
Q2 | $4.61M | Hold |
655,057
| – | – | 0.32% | 38 |
|
|
2023
Q1 | $4M | Hold |
655,057
| – | – | 0.28% | 36 |
|
|
2022
Q4 | $4.19M | Hold |
655,057
| – | – | 0.48% | 35 |
|
|
2022
Q3 | $6.28M | Hold |
655,057
| – | – | 0.69% | 35 |
|
|
2022
Q2 | $7.23M | Hold |
655,057
| – | – | 0.73% | 29 |
|
|
2022
Q1 | $10.9M | Buy |
655,057
+354,057
| +118% | +$5.9M | 0.75% | 28 |
|
|
2021
Q4 | $5.75M | Buy |
+301,000
| New | +$5.75M | 0.35% | 45 |
|
|
2019
Q3 | – | Sell |
-1,600,000
| Closed | -$39.2M | – | 18 |
|
|
2019
Q2 | $39.2M | Hold |
1,600,000
| – | – | 3.68% | 7 |
|
|
2019
Q1 | $15.2M | Hold |
1,600,000
| – | – | 1.52% | 18 |
|
|
2018
Q4 | $14.2M | Buy |
+1,600,000
| New | +$14.2M | 1.81% | 15 |
|